Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T19229 | Target Info | |||
Target Name | Proton-coupled folate transporter (SLC46A1) | ||||
Synonyms |
Solute carrier family 46 member 1; PCFT/HCP1; PCFT; Heme carrier protein 1; HCP1; G21
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | SLC46A1 | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Dihydrofolate reductase (DHFR) | Successful Target | ||||
UniProt ID | DYR_HUMAN | |||||
Gene Name | DHFR | |||||
Synonyms |
DYR; DHFRP1
Click to Show/Hide
|
|||||
Representative Drug(s) | Methotrexate | Drug Info | Ki = 0.00034 nM | [1] | ||
Co-Target Name | Solute carrier family 19 member 1 (SLC19A1) | Successful Target | ||||
UniProt ID | S19A1_HUMAN | |||||
Gene Name | SLC19A1 | |||||
Synonyms |
Reduced folate carrier protein; RFC1; RFC; Placental folate transporter; Intestinal folate carrier 1; IFC-1; Folate transporter 1; FOLT; FLOT1
Click to Show/Hide
|
|||||
Representative Drug(s) | Methotrexate | Drug Info | IC50 = 12 nM | [2] | ||
Co-Target Name | Folate receptor alpha (FOLR1) | Successful Target | ||||
UniProt ID | FOLR1_HUMAN | |||||
Gene Name | FOLR1 | |||||
Synonyms |
Ovarian tumorassociated antigen MOv18; KB cells FBP; Folate receptor, adult; Folate receptor 1; FRalpha; FOLR1; Adult folatebinding protein
Click to Show/Hide
|
|||||
Representative Drug(s) | Methotrexate | Drug Info | IC50 = 114 nM | [3] | ||
Co-Target Name | Folate receptor beta (FOLR2) | Literature-reported Target | ||||
UniProt ID | FOLR2_HUMAN | |||||
Gene Name | FOLR2 | |||||
Synonyms |
Placental folate-binding protein; Folate receptor, fetal/placental; Folate receptor type-beta; Folate receptor 2; FR-beta; FOLR2
Click to Show/Hide
|
|||||
Representative Drug(s) | Methotrexate | Drug Info | IC50 = 106 nM | [3] | ||
Co-Target Name | Nuclear receptor coactivator 3 (NCOA3) | Literature-reported Target | ||||
UniProt ID | NCOA3_HUMAN | |||||
Gene Name | NCOA3 | |||||
Synonyms |
bHLHe42; Thyroid hormone receptor activator molecule 1; TRAM1; TRAM-1; Steroid receptor coactivator protein 3; SRC-3; Receptor-associated coactivator 3; RAC3; RAC-3; PCIP; NCoA-3; Class E basic helix-loop-helix protein 42; CBP-interacting protein; Amplified in breast cancer-1 protein; Amplified in breast cancer 1 protein; AIB1 (SRC-3); AIB1; AIB-1; ACTR
Click to Show/Hide
|
|||||
Representative Drug(s) | Methotrexate | Drug Info | IC50 = 210.97 nM | [4] | ||
Co-Target Name | Thymidylate synthase (TYMS) | Literature-reported Target | ||||
UniProt ID | TYSY_HUMAN | |||||
Gene Name | TYMS | |||||
Synonyms |
TSase; TS
Click to Show/Hide
|
|||||
Representative Drug(s) | Methotrexate | Drug Info | Ki = 600 nM | [1] | ||
Co-Target Name | Thymidylate synthase/GAR transformylase/AICAR transformylase (TYMS/GAR/TATIC) | Co-Target | ||||
UniProt ID | TYSY_HUMAN; PUR2_HUMAN; PUR9_HUMAN | |||||
Gene Name | TYMS; GART; ATIC | |||||
Synonyms |
Tsase; PRGS; PURH
Click to Show/Hide
|
|||||
Representative Drug(s) | Methotrexate | Drug Info | IC50 = 10 nM | [5] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structure-based selectivity optimization of piperidine-pteridine derivatives as potent Leishmania pteridine reductase inhibitors. J Med Chem. 2012 Oct 11;55(19):8318-29. | ||||
REF 2 | Structure-activity profiles of novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolates with modified amino acids for cellular uptake by folate receptors alpha and beta and the proton-coupled folate transporter. J Med Chem. 2014 Oct 9;57(19):8152-66. | ||||
REF 3 | Tumor Targeting with Novel Pyridyl 6-Substituted Pyrrolo[2,3- d]Pyrimidine Antifolates via Cellular Uptake by Folate Receptor alpha and the Proton-Coupled Folate Transporter and Inhibition of De Novo Purine Nucleotide Biosynthesis. J Med Chem. 2018 Mar 8;61(5):2027-40. | ||||
REF 4 | PubChem BioAssay: 2017 update. Nucleic Acids Res. 2017 Jan 4;45(D1):D955-D963. | ||||
REF 5 | Novel 6-substituted benzoyl and non-benzoyl straight chain pyrrolo[2,3-d]pyrimidines as potential antitumor agents with multitargeted inhibition of TS, GARFTase and AICARFTase. Eur J Med Chem. 2017 Oct 20;139:531-541. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.